Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Oanh Dang
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0007-9505-945X
Observed ORCID:
0009-0007-9505-945X
OpenAlex ID:
A5076602978
Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System
2021
·
Kory Kreimeyer
, Oanh Dang
, et al.
·
Computers in Biology and Medicine
·
61
Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology
2018
·
Thomas Ly
, Carol Pamer
, et al.
·
Journal of Biomedical Informatics
·
56
ADE Eval: An Evaluation of Text Processing Systems for Adverse Event Extraction from Drug Labels for Pharmacovigilance
2020
·
Samuel Bayer
, Cheryl Clark
, et al.
·
Drug Safety
·
27
PDF
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration
2024
·
Robert Ball
, Andrew H Talal
, et al.
·
Journal of Medical Internet Research
·
25
Adverse Event extraction from Structured Product Labels using the Event-based Text-mining of Health Electronic Records (ETHER) system
2018
·
Abhishek Pandey
, Kory Kreimeyer
, et al.
·
Health Informatics Journal
·
22
Information Visualization Platform for Postmarket Surveillance Decision Support
2020
·
Jonathan Spiker
, Kory Kreimeyer
, et al.
·
Drug Safety
·
21
Increased Confidence in Deduplication of Drug Safety Reports with Natural Language Processing of Narratives at the US Food and Drug Administration
2022
·
Kory Kreimeyer
, Oanh Dang
, et al.
·
Frontiers in Drug Safety and Regulation
·
18
RxBERT: Enhancing drug labeling text mining and analysis with AI language modeling
2023
·
Leihong Wu
, Magnus Gray
, et al.
·
Experimental Biology and Medicine
·
17
PDF
Deduplicating the FDA adverse event reporting system with a novel application of network-based grouping
2025
·
Kory Kreimeyer
, Jonathan Spiker
, et al.
·
Journal of Biomedical Informatics
·
16
Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA Labeling
2024
·
George A. Neyarapally
, Leihong Wu
, et al.
·
Drug Safety
·
9
PDF
Characterizing the FDA Adverse Event Reporting System (FAERS) as a Network to Improve Pattern Discovery
2025
·
Raechel Davis
, Oanh Dang
, et al.
·
Drug Safety
·
5
Rapid development of the FDA ACMT COVID-19 ToxIC (FACT) pharmacovigilance pilot project to monitor adverse events reported in association with COVID-19 therapeutics
2021
·
Kim Aldy
, Pamela Wax
, et al.
·
Clinical Toxicology
·
1
Does generative AI mean the “end of history” for pharmacovigilance automation? towards a framework for the future of human-AI systems
2026
·
Leihong Wu
, Joshua Xu
, et al.
·
Frontiers in Drug Safety and Regulation
PDF
Show more works
View as search
Works count:
13
Citation count:
278
H-index:
9
I10-index:
9
Year
Topic
Type